Andrew R. Allen
- Pulmonary and Respiratory Medicine top 5%
- Molecular Biology
- Oncology top 10%
- Immunology
- Cancer Research
- Co-authors
- Charles D. PuseyG. GaskinJennifer SmithSarah Jaw‐TsaiLindsey RolfeDorian O. HaskardRoy R. LobbD. Ross Camidge
- Topics
- Lung Cancer Treatments and Mutations (10 papers)PARP inhibition in cancer therapy (9 papers)Fibroblast Growth Factor Research (7 papers)
- Partner nations
- United StatesUnited KingdomFrance
In The Last Decade
Andrew R. Allen
49 papers receiving 936 citations
Peers
Comparison fields: 5 of 96
- Pulmonary and Respiratory Medicine 392
- Molecular Biology 372
- Oncology 361
- Immunology 131
- Cancer Research 123
Countries citing papers authored by Andrew R. Allen
This map shows the geographic impact of Andrew R. Allen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew R. Allen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew R. Allen more than expected).
Fields of papers citing papers by Andrew R. Allen
This network shows the impact of papers produced by Andrew R. Allen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew R. Allen. The network helps show where Andrew R. Allen may publish in the future.
Co-authorship network of co-authors of Andrew R. Allen
This figure shows the co-authorship network connecting the top 25 collaborators of Andrew R. Allen. A scholar is included among the top collaborators of Andrew R. Allen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew R. Allen. Andrew R. Allen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 22 | |
| 3 | A phase 2, randomized, open-label study of lucitanib in patients with FGF aberrant metastatic breast cancer. | 2 |
| 4 | 3 | |
| 5 | 2 | |
| 6 | 147 | |
| 7 | 19 | |
| 8 | 11 | |
| 9 | 1 | |
| 10 | Epigenetic alterations and cancer: new targets for therapy. | 5 |
| 11 | 1 | |
| 12 | 1 | |
| 13 | 63 | |
| 14 | 34 | |
| 15 | 34 | |
| 16 | 40 | |
| 17 | 37 | |
| 18 | 83 | |
| 19 | 9 | |
| 20 | 14 |
About Andrew R. Allen
Andrew R. Allen is a scholar working on Immunology and Allergy, Oncology and Cancer Research, having authored 49 papers that have together received 964 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (10 papers), PARP inhibition in cancer therapy (9 papers) and Fibroblast Growth Factor Research (7 papers). The work is most often cited by research in Nephrology (121 citations), Immunology and Allergy (86 citations) and Oncology (361 citations). Andrew R. Allen has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Charles D. Pusey, G. Gaskin, Jennifer Smith, Sarah Jaw‐Tsai, Lindsey Rolfe, Dorian O. Haskard, Roy R. Lobb, D. Ross Camidge, Jean‐Charles Soria and Lecia V. Sequist. Their work appears in journals such as Journal of Clinical Oncology, Blood and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.